[1]
“Bevacizumab and etoposide combination chemotherapy in patients with recurrent malignant gliomas who failed bevacizumab”, Drugs Ther Studies, vol. 2, no. 1, p. e6, Feb. 2012, doi: 10.4081/dts.2012.e6.